Shandong Sito Bio-technology Co., Ltd.
SHZ: 300583.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Lianbiao Jin
- Employees
- 959
- Headquarters
- Heze, China
- IPO year
- 2017
- Market cap
- CN¥3.0B
- Website
- https://www.sitobiotech.com
Loading 300583…
Loading profile data…Frequently asked questions about 300583
What does Shandong Sito Bio-technology Co., Ltd. (300583.SZ) do?
Shandong Sito Bio-technology Co., Ltd. researches and develops new steroid hormones, intermediates, and derivatives. Its products include 9a-hydroxyandrostenedione, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, dexamethasone epoxy hydrolysate, progesterone intermediate, opener, tetraene, androstenedione, ketal,...
Where does 300583.SZ trade?
Shandong Sito Bio-technology Co., Ltd. (300583.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300583.SZ in?
Shandong Sito Bio-technology Co., Ltd. (300583.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Shandong Sito Bio-technology Co., Ltd.?
Lianbiao Jin is the chief executive officer of Shandong Sito Bio-technology Co., Ltd. (300583.SZ).
Where is Shandong Sito Bio-technology Co., Ltd. headquartered?
Shandong Sito Bio-technology Co., Ltd. is headquartered in China.
Does 300583.SZ pay a dividend?
Yes — Shandong Sito Bio-technology Co., Ltd. (300583.SZ) paid a trailing twelve-month dividend of CNY 0.02 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300583.SZ go public?
Shandong Sito Bio-technology Co., Ltd. (300583.SZ) completed its initial public offering in 2017.